Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-18 5:14 pm Purchase |
2023-08-09 | 13G | IO Biotech, Inc. IOBT |
Samsara BioCapital, L.P. | 3,640,015 5.500% |
3,640,015 (New Position) |
Filing History |
| 2023-11-22 4:15 pm Sale |
2023-08-11 | 13D | Chinook Therapeutics, Inc. KDNY |
Samsara BioCapital, L.P. | 0 0.000% |
-5,181,557 (Position Closed) |
Filing History |
| 2023-11-21 4:15 pm Purchase |
2023-11-14 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
Samsara BioCapital, L.P. | 4,121,689 10.700% |
4,121,689 (New Position) |
Filing History |
| 2023-10-20 4:15 pm Purchase |
2023-01-15 | 13D | Syros Pharmaceuticals, Inc. SYRS |
Samsara BioCapital, L.P. | 1,605,546 7.500% |
1,605,546 (New Position) |
Filing History |
| 2023-10-18 5:27 pm Purchase |
2023-10-16 | 13D | Scholar Rock Holding Corporation SRRK |
Samsara BioCapital, L.P. | 7,878,302 11.000% |
2,202,226 (+38.80%) |
Filing History |
| 2023-08-25 4:15 pm Purchase |
2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA |
Samsara BioCapital, L.P. | 2,780,261 5.600% |
2,780,261 (New Position) |
Filing History |
| 2023-02-24 4:00 pm Purchase |
2023-02-14 | 13D | COMPASS Pathways plc CMPS |
Samsara BioCapital, L.P. | 4,521,805 11.100% |
4,521,805 (New Position) |
Filing History |
| 2023-02-14 5:07 pm Purchase |
2022-12-31 | 13G | Graphite Bio, Inc. GRPH |
Samsara BioCapital, L.P. | 1,213,867 14.600% |
92,162 (+8.22%) |
Filing History |
| 2023-02-14 5:05 pm Purchase |
2022-06-22 | 13D | Scholar Rock Holding Corporation SRRK |
Samsara BioCapital, L.P. | 5,676,076 10.800% |
5,676,076 (New Position) |
Filing History |
| 2023-02-14 5:00 pm Purchase |
2021-04-23 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
Samsara BioCapital, L.P. | 2,260,652 9.100% |
2,260,652 (New Position) |
Filing History |
| 2023-02-14 4:56 pm Purchase |
2022-04-28 | 13D | Nkarta, Inc. NKTX |
Samsara BioCapital, L.P. | 2,868,035 5.900% |
833,332 (+40.96%) |
Filing History |
| 2022-06-01 4:00 pm Purchase |
2020-10-05 | 13D | Chinook Therapeutics, Inc. KDNY |
Samsara BioCapital, L.P. | 5,181,557 8.400% |
5,181,557 (New Position) |
Filing History |
| 2022-02-14 06:06 am Purchase |
2021-12-31 | 13G | Graphite Bio, Inc. GRPH |
Samsara BioCapital, L.P. | 1,121,705 13.500% |
60,044 (+5.66%) |
Filing History |
| 2021-07-09 4:31 pm Purchase |
2021-06-29 | 13G | Graphite Bio, Inc. GRPH |
Samsara BioCapital, L.P. | 1,061,660 12.800% |
1,061,660 (New Position) |
Filing History |
| 2020-07-22 3:33 pm Purchase |
2020-07-14 | 13D | Nkarta, Inc. NKTX |
Samsara BioCapital, L.P. | 2,034,703 6.300% |
2,034,703 (New Position) |
Filing History |